A citation-based method for searching scientific literature

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial.
Iain B McInnes, Frank Behrens, Philip J Mease, Arthur Kavanaugh, Christopher Ritchlin, Peter Nash, Jordi Gratacós Masmitja, Philippe Goupille, Tatiana Korotaeva, Alice B Gottlieb, Ruvie Martin, Kevin Ding, Pascale Pellet, Shephard Mpofu, Luminita Pricop. Lancet 2020
Times Cited: 91



Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
Philip J Mease, Désirée van der Heijde, Christopher T Ritchlin, Masato Okada, Raquel S Cuchacovich, Catherine L Shuler, Chen-Yen Lin, Daniel K Braun, Chin H Lee, Dafna D Gladman. Ann Rheum Dis 2017
Times Cited: 315




List of shared articles



Times cited

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis.
Maria Sole Chimenti, Arianna D'Antonio, Paola Conigliaro, Sara Ferrigno, Andrea Vendola, Mario Ferraioli, Paola Triggianese, Luisa Costa, Francesco Caso, Roberto Perricone. Biologics 2020
9

A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains.
Tiago Torres, Anabela Barcelos, Paulo Filipe, João Eurico Fonseca. Front Med (Lausanne) 2021
6

Ixekizumab for Psoriatic Arthritis: Safety, Efficacy, and Patient Selection.
John Miller, Abin P Puravath, Ana-Maria Orbai. J Inflamm Res 2021
0

Interleukin-17 inhibitor, is it safer than tumor necrosis factor inhibitor?
Jinxian Huang, Lijun Zhang, James C-C Wei. Int J Rheum Dis 2021
0

Current and emerging biologic and small molecule systemic treatment options for psoriasis and psoriatic arthritis.
Christine P Lin, Joseph F Merola, Elizabeth B Wallace. Curr Opin Pharmacol 2022
0

From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis.
Ettore Silvagni, Sonia Missiroli, Mariasole Perrone, Simone Patergnani, Caterina Boncompagni, Alessandra Bortoluzzi, Marcello Govoni, Carlotta Giorgi, Stefano Alivernini, Paolo Pinton,[...]. Front Pharmacol 2021
5

Choosing the right treatment for patients with psoriatic arthritis.
Maria Noviani, Marie Feletar, Peter Nash, Ying Ying Leung. Ther Adv Musculoskelet Dis 2020
9

Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety.
Frank Kolbinger, Franco Di Padova, Atul Deodhar, Jason E Hawkes, Christine Huppertz, Torsten Kuiper, Iain B McInnes, Christopher T Ritchlin, David Rosmarin, Georg Schett,[...]. Pharmacol Ther 2022
5

The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis.
Hiroyuki Tsukazaki, Takashi Kaito. Int J Mol Sci 2020
28

Choosing the Appropriate Target for the Treatment of Psoriatic Arthritis: TNFα, IL-17, IL-23 or JAK Inhibitors?
Chrysoula G Gialouri, Gerasimos Evangelatos, George E Fragoulis. Mediterr J Rheumatol 2022
1

Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes.
Iain B McInnes, Laura M Sawyer, Kristen Markus, Corinne LeReun, Celia Sabry-Grant, Philip S Helliwell. RMD Open 2022
4

Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.
Philip J Mease, Iain B McInnes, Lai-Shan Tam, Kiefer Eaton, Steve Peterson, Agata Schubert, Soumya D Chakravarty, Anna Parackal, Chetan S Karyekar, Sandhya Nair,[...]. Rheumatology (Oxford) 2021
19

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52.
Josef S Smolen, Philip Mease, Hasan Tahir, Hendrik Schulze-Koops, Inmaculada de la Torre, Lingnan Li, Maja Hojnik, Christophe Sapin, Masato Okada, Roberto Caporali,[...]. Ann Rheum Dis 2020
27

Peripheral Enthesitis in Spondyloarthritis: Lessons from Targeted Treatments.
Gurjit S Kaeley, Jaspreet K Kaler. Drugs 2020
0

Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers.
William Saalfeld, Amanda M Mixon, Jonna Zelie, Eileen J Lydon. Rheumatol Ther 2021
4

Dawn of Precision Medicine in Psoriatic Arthritis.
Ippei Miyagawa, Yoshiya Tanaka. Front Med (Lausanne) 2022
2

Current treatments and recommendations for Psoriatic Arthritis.
Arani Vivekanantham, Dylan McGagh, Laura C Coates. Best Pract Res Clin Rheumatol 2021
5

Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results.
Josef S Smolen, Stefan Siebert, Tatiana V Korotaeva, Carlo Selmi, Paul Bergmans, Elisa Gremese, Beatriz Joven-Ibáñez, Gkikas Katsifis, Wim Noël, Michael T Nurmohamed,[...]. Ann Rheum Dis 2021
3

Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis.
Sueli Carneiro, Penelope Esther Palominos, Sônia Maria Alvarenga Anti, Rodrigo Luppino Assad, Rafaela Silva Guimarães Gonçalves, Adriano Chiereghin, Andre Marun Lyrio, Antônio Carlos Ximenes, Carla Gonçalves Saad, Célio Roberto Gonçalves,[...]. Adv Rheumatol 2021
1

A Practical Guide for Assessment of Skin Burden in Patients With Psoriatic Arthritis.
Fazira R Kasiem, Annelieke Pasma, Jolanda J Luime, Ilja Tchetverikov, Kim Wervers, Lindy-Anne Korswagen, Natasja Denissen, Yvonne P M Goekoop-Ruiterman, Maikel van Oosterhout, Faouzia Fodili,[...]. J Rheumatol 2022
1

Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms.
Hoi Ki Joshua Tam, Philip C Robinson, Peter Nash. Curr Rheumatol Rep 2022
0

Applying precision medicine to unmet clinical needs in psoriatic disease.
Deepak R Jadon, Carmel Stober, Stephen R Pennington, Oliver FitzGerald. Nat Rev Rheumatol 2020
16

Updated therapies for the management of Psoriatic Arthritis.
Atrin Toussi, Natalia Maverakis, Stephanie T Le, Soumajyoti Sarkar, Smriti K Raychaudhuri, Siba P Raychaudhuri. Clin Immunol 2020
8

Effect of interleukin-17A inhibitor in Japanese patients with psoriatic arthritis compared with tumor necrosis factor-alpha inhibitor.
Takuya Izumiyama, Yu Mori, Itsuki Oizumi, Soshi Hamada, Hiroaki Kurishima, Hitoshi Terui, Ryoko Omori-Shimada, Kenshi Yamasaki, Eiji Itoi. J Orthop Surg (Hong Kong) 2021
0


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy